查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1521384

全球充血性心臟衰竭治療設備市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Congestive Heart Failure Treatment Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 130 Pages | 商品交期: 最快1-2個工作天內

價格

全球充血性心臟衰竭治療設備市場需求預計將從 2023 年的 282.2 億美元達到 2032 年近 521.4 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.06%。

充血性心臟衰竭 (CHF) 治療設備包括專門用於管理和改善心臟衰竭症狀的各種醫療設備。這些設備在為慢性心臟衰竭患者提供治療支援方面發揮著至關重要的作用，慢性心臟衰竭患者的心臟難以有效泵血，導致肺部和身體其他部位積液。充血性心臟衰竭治療裝置的主要目標是增強心臟功能、緩解症狀並提高患者的整體生活品質。

市場動態

由於全球心臟衰竭盛行率不斷上升，特別是在老年族群中，心臟衰竭治療設備市場正在顯著成長。隨著預期壽命的延長和生活方式的演變，心臟衰竭的發生率持續上升，需要先進的治療方案，包括起搏器、植入式心律轉復除顫器(ICD) 和心臟再同步治療(CRT ) 設備等植入式設備。心臟護理領域的技術進步也是市場成長的關鍵驅動力。設備小型化、遠端監控無線連接和延長電池壽命等創新正在提高充血性心臟衰竭治療設備的功效和可用性。這些進步透過向醫療保健提供者提供即時資料來改善患者的治療結果，並透過個人化和及時的干涉措施有助於更好地管理慢性病。

此外，有利的報銷政策和不斷增加的醫療支出正在推動市場擴張。政府和醫療機構越來越認知到預防措施和先進治療方案在治療心臟衰竭等慢性疾病方面的成本效益，從而支持採用充血性心臟衰竭治療設備。然而，與設備植入和維護相關的高昂初始成本以及對設備核准和患者安全的嚴格監管要求對小型充血性心臟衰竭治療設備製造商構成了進入市場的障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球充血性心臟衰竭治療設備市場的各個細分市場進行了包容性評估。充血性心臟衰竭治療設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

充血性心臟衰竭治療設備市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 除顫器（植入式心臟復律去顫器 (ICD)（經靜脈 ICD（單腔 ICD、雙腔 ICD）、皮下 ICD））
  • 體外心臟去顫器（手動體外心臟去顫器、自動體外心臟去顫器（半自動體外心臟去顫器、全自動體外心臟去顫器）、穿戴式體外心臟去顫器）
  • 心律調節器（植入式心律調節器、體外心律調節器）
  • 心臟再同步治療設備（心臟再同步治療去顫器(CRT-D)（MRI 相容CRT-D 設備、傳統CRT-D 設備）、心臟再同步治療心律調節器(CRT-P)（MRI 相容CRT- P 設備、傳統CRT -P 設備））
  • 心室輔助裝置 (VAD)（左心室輔助裝置 (LVAD)、右心室輔助裝置 (RVAD)、雙心室輔助裝置 (BIVAD)、經皮心室輔助裝置 (PVAD)、全人工心臟）
  • 其他產品

按最終用途

  • 醫院
  • 心臟診所
  • 門診手術中心
  • 其他最終用戶

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲充血性心臟衰竭治療設備市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。充血性心臟衰竭治療設備市場的主要參與者包括 Abbott Laboratories、Biotronik SE & Co. Ltd.、LivaNova PLC、Medico SPA、Medtronic Plc、Mipu MedicalPort Scientific Corporation Corporation 、Oscor Inc.、Schiller AG、Shree Pacetronix Ltd.、St. Jude Medical Inc.、Stryker Corporation、Terumo Corporation。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：充血性心臟衰竭治療設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球充血性心臟衰竭治療設備市場分析：依產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 除顫器（植入式心臟復律去顫器 (ICD)（經靜脈 ICD（單腔 ICD 雙腔 ICD）、皮下 ICD））
  • 體外心臟去顫器（手動體外心臟去顫器、自動體外心臟去顫器（半自動體外心臟去顫器、全自動體外心臟去顫器）、穿戴式體外心臟去顫器）
  • 心律調節器（植入式心律調節器、體外心律調節器）
  • 心臟再同步治療設備（心臟再同步治療去顫器(CRT-D)（MRI 相容CRT-D 設備、傳統CRT-D 設備）、心臟再同步治療心律調節器(CRT-P)（MRI 相容CRT- P 設備、傳統CRT -P 設備））
  • 心室輔助裝置 (VAD)（左心室輔助裝置 (LVAD)、右心室輔助裝置 (RVAD)、雙心室輔助裝置 (BIVAD)、經皮心室輔助裝置 (PVAD)、全人工心臟）
  • 其他產品

第 6 章：全球充血性心臟衰竭治療設備市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途進行歷史和預測資料分析
  • 醫院
  • 心臟診所
  • 門診手術中心
  • 其他最終用戶

第 7 章：全球充血性心臟衰竭治療設備市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 8 章：充血性心臟衰竭治療設備公司的競爭格局

  • 充血性心臟衰竭治療設備市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 9 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Abbott Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Biotronik SE & Co. KG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boston Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Koninkilijke Philips NV
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lepu Medical Technology Co. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • LivaNova PLC
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medico SPA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medtronic Plc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • MicroPort Scientific Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Oscor Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Schiller AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Shree Pacetronix Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • St. Jude Medical Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Stryker Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Terumo Corporation
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115266

The global demand for Congestive Heart Failure Treatment Device Market is presumed to reach the market size of nearly USD 52.14 Billion by 2032 from USD 28.22 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Congestive Heart Failure (CHF) treatment devices encompass a diverse range of medical devices specifically designed to manage and improve the symptoms of heart failure. These devices play a crucial role in providing therapeutic support to patients with CHF, a chronic condition in which the heart struggles to efficiently pump blood, leading to fluid accumulation in the lungs other areas of the body. The primary goal of congestive heart failure treatment devices is to enhance cardiac function, alleviate symptoms, and enhance patients' overall quality of life.

MARKET DYNAMICS

The CHF treatment device market is witnessing significant growth driven by the increasing prevalence of heart failure globally, particularly among elderly populations. As life expectancy rises and lifestyles evolve, the incidence of heart failure continues to escalate, necessitating advanced treatment options, including implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Technological advancements in cardiac care are also pivotal drivers of market growth. Innovations such as miniaturization of devices, wireless connectivity for remote monitoring, and improved battery life are enhancing the efficacy and usability of congestive heart failure treatment devices. These advancements improve patient outcomes by providing real-time data to healthcare providers and contribute to better management of chronic conditions through personalized and timely interventions.

Moreover, favorable reimbursement policies and increasing healthcare expenditure are bolstering market expansion. Governments and healthcare organizations increasingly recognize the cost-effectiveness of preventive measures and advanced treatment options for managing chronic diseases like heart failure, thereby supporting the adoption of congestive heart failure treatment devices. However, the high initial costs associated with device implantation and maintenance and stringent regulatory requirements for device approval and patient safety pose barriers to market entry for smaller congestive heart failure treatment device manufacturers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Congestive Heart Failure Treatment Device. The growth and trends of Congestive Heart Failure Treatment Device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Congestive Heart Failure Treatment Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD))
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator)
  • Pacemakers (Implantable Pacemakers, External Pacemakers)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices))
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart)
  • Other Products

By End-Use

  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgical Centers
  • Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Congestive Heart Failure Treatment Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Congestive Heart Failure Treatment Device market include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninkilijke Philips N.V., Lepu Medical Technology Co. Ltd., LivaNova PLC, Medico S.P.A., Medtronic Plc, MicroPort Scientific Corporation, Oscor Inc., Schiller AG, Shree Pacetronix Ltd., St. Jude Medical Inc., Stryker Corporation, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CONGESTIVE HEART FAILURE TREATMENT DEVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Historic and Forecast Sales By Regions
  • 5.4. External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Historic and Forecast Sales By Regions
  • 5.5. Pacemakers (Implantable Pacemakers, External Pacemakers) Historic and Forecast Sales By Regions
  • 5.6. Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Historic and Forecast Sales By Regions
  • 5.7. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Historic and Forecast Sales By Regions
  • 5.8. Other Products Historic and Forecast Sales By Regions

6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data Analysis By End-Use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Clinics Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Other End-Users Historic and Forecast Sales By Regions

7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONGESTIVE HEART FAILURE TREATMENT DEVICE COMPANIES

  • 8.1. Congestive Heart Failure Treatment Device Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CONGESTIVE HEART FAILURE TREATMENT DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Biotronik SE & Co. KG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Koninkilijke Philips N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Lepu Medical Technology Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. LivaNova PLC
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medico S.P.A.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Medtronic Plc
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. MicroPort Scientific Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Oscor Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Schiller AG
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Shree Pacetronix Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. St. Jude Medical Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Stryker Corporation
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Terumo Corporation
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Congestive Heart Failure Treatment Device Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Congestive Heart Failure Treatment Device Report
  • Market Research Process
  • Market Research Methodology
  • Global Congestive Heart Failure Treatment Device Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.